AzTrials
AzTrials

Emergency MedicineNCT03457272

Development and Evaluation of a Patient Safety Model

A study testing New risk assessment in people with Emergency Medicine, run by University of Aarhus at 4 sites in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Despite systems for early detection of critical illness, 12% of patients in the emergency department develop clinical deterioration with an increased risk of death as a result. There is a need for a intervention to support the identification and clinical management of patients at risk of clinical deterioration earlier… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Emergency Medicine
What is being tested?
New risk assessment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
34,556 participants
Where
4 sitesDenmark
Study dates
30 Oct 2017to 31 May 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult somatic patients (≥18 years) admitted to the participating Emergency Departments

Who cannot join

  • Patients with injuries caused by trauma
  • Patients received with cardiac arrest, as a surgical or medical call (can participate if admitted to the Emergency Department and not directly transferred to the Intensive Care Unit)
  • Patients hospitalized with a psychiatric diagnosis as the primary cause of admission

Trial locations and contacts

4 sites in 1 country.

Denmark4 sites
  • Herning Regional Hospital

    Herning, 7400

  • Horsens Regional Hospital

    Horsens, 8700

  • Randers Regional Hospital

    Randers, 8930

  • Viborg Regional Hospital

    Viborg, 8800

Other trials in Denmark

About this study

Official title: Development and Evaluation of a Patient Safety Model Targeting Severe Clinical Deterioration and Safety Awareness in the Emergency Department

Despite systems for early detection of critical illness, 12% of patients in the emergency department develop clinical deterioration with an increased risk of death as a result.

There is a need for a intervention to support the identification and clinical management of patients at risk of clinical deterioration earlier hospitalization. The Cincinnati Children's Hospital has introduced a model that systematically complements systems for early detection of critical illness with the assessment of patient and relatives concern, clinical intuition and concern of the staff. In addition, the model includes formalized organizational processes aimed at systematic review of risk patients and early treatment efforts. Studies from United States indicate that the model can lead to reduction of serious incidental events and increase the staff awareness of the situation. The Cincinnati model is designed for children and has not yet been studied in a controlled study.

Purpose To develop and investigate the impact of a Danish patient safety model. Method A literature review is conducted to identify risk factors that should be included in a model aimed at detecting and managing clinical deterioration. A patient safety model is developed on the basis of the literature review and the Cincinnati model and is tested in a pilot study. In a controlled intervention study, the effect is investigated against severe clinical deterioration. The intervention is carried out at the emergency departments at Horsens Regional Hospital and Viborg Regional Hospital with the regional hospitals in Randers and Herning as control departments.

Read the detailed description

Preventing deterioration in acute patients is of great interest internationally. Studies demonstrate that clinical deterioration can be measured up to 24 hours before a heart arrest or intensive care admission in the vital signs. Therefore, the health services have implemented early warning systems to detect deterioration and critical illness.

Despite the systems, 12% of patients in an emergency department still develop severe clinical deterioration with increased risk of death as a result. Research indicates that the reasons for this may be diverse and further action to support the early identification and treatment of patients at risk of deterioration is needed.

Cincinnati Children's Hospital has introduced a patient safety model to ensure identification and mitigation of patient risk through escalated observation, care and treatment depending on the individual's risk for clinical deterioration. The model includes early warning systems, but as something new, it is supplemented with systematic evaluation of more subjective factors such as staff's clinical gaze and concerns, patient/relatives' concerns, communication problems and high risk therapy.

In an observational study, the Cincinnati Situation Awareness model was found to be associated with a near 50% reduction in unsafe intensive care unit transfers and decrease in severe safety events. However, the model has so far not been evaluated in a controlled study or an adult population.

The study will consist of three substudies; the overall study design is based on a framework for implementation of complex interventions following a four-step-process entailing development, pilot test, evaluation and reporting.

Study I. The study will consist of a systematic review and aims to identify risk factors associated with severe clinical deterioration and severe safety events that should ultimately be considered for inclusion in the patient safety model.

The aim of study II is to develop a patient safety model based on the components in the Cincinnati Situation Awareness model and explore its feasibility. The Danish patient safety model is expected to consist of systematic patient risk screening, bed huddles and audits of intensive care unit transfers.

Relevant aspects that should be included in the systematic patient risk screening are identified based on the literature study. A multidisciplinary panel is established to ensure that the choice of risk parameters is made on the basis of risk factors with the highest impact and the applicability to standard care.

A pilot test of the model will be conducted to evaluate the feasibility of methods and procedures based on the principles of the Medical Research Council guidance.

The final model will be investigated in a prospective controlled intervention study design to examine the effect in relation to severe clinical deterioration, safety awareness and serious adverse events (Study III).

The study will follow a Quasi-experimental design. The intervention will be implemented at the Emergency Departments and Intensive Care Units at Horsens and Viborg Regional Hospitals with the Emergency Departments at Herning and Randers Regional Hospitals as controls.

A positive outcome is expected to increase patient safety by reducing patients with severe deterioration, serious adverse events and increase staff safety awareness.

Being tested
New risk assessment
Keywords
Patient Safety, Risk Factors, Quality Indicators, Health Care, Risk Assessment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • New risk assessmentOther

    Consists of a simple physiological scoring system and an assessment of patients who should assist healthcare professionals in identifying patients at risk of clinical deterioration earlier and support timely response and escalation of observation, care and treatment and thereby prevent the development of severe clinical deterioration.

    The patients included in the study will be monitored using the new risk assessment tool with different intervals according to the patients' conditions. Underlying the tool are algorithms of action for intervention in the critically ill patient, inter professional guidelines and guidance for standardized monitoring, escalation plans and huddles.

Study groups in NCT03457272
Study groupRoleWhat they receive
New risk assessmentExperimentalNew risk assesment
Receives: Other: New risk assessment
StandardNo interventionStandard risk assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The proportion of patients with severe clinical deterioration in the ED

    Severe clinical deterioration will be measured by the early warning system used in Central Denmark Region based on vital signs collected from medical records. The score is aggregated and the vital signs include respiratory rate, SatO2, systolic blood pressure, pulse, temperature and level of consciousness measured by APVU.

    The initial deterioration process from score 0-1 will be considered as "no deterioration". Deterioration directly to score 2 and above, or deterioration from score ≥2 and further will be considered severe.

    Measured: Participants will be followed for the length of stay in the Emergency Department, an expected period of 48 hours

Secondary outcomes (10)
  1. Safety awareness

    Staff safety awareness will be measured in the last months of the baseline period and in the last months of the intervention period by the Safety Attitudes Questionnaire adapted and validated for Danish hospital settings. The questionnaire consists of 31 items rated on a 5-point Likert type scale. The questionnaire comprises six subscales: teamwork climate, safety climate, stress recognition, job satisfaction, working conditions, and perceptions of unit management.

    Measured: up to 4 weeks (in baseline and in intervention)

  2. Proportion of participants with severe safety events

    Severe safety events is a composite outcome consisting of either unexpected in-hospital cardiac/respiratory arrest, unexpected in-hospital death (when no Do-Not-Resuscitate order has been prescribed) and unanticipated intensive care unit transfer from the Emergency Department

    Measured: Participants will be followed for the duration of the hospital stay in the Emergency Department, an expected average of 17 hours

  3. Proportion of participants admitted to the Intensive Care Units from the Emergency Departments

    Proportion of participants referred to the Intensive Care Units from the Emergency Departments

    Measured: Participants will be followed for the duration of the hospital stay in the Emergency Department, an expected average of 17 hours

  4. Proportion of participants admitted to the Intensive Care Units from the wards

    Proportion of participants admitted to the Intensive Care Units from the wards

    Measured: Participants will be followed for the duration of hospital stay, an expected average of 1 week

  5. Length of stay at the Intensive Care Unit

    The length of time patients spend in the Intensive Care Units

    Measured: Participants will be followed for the duration of hospital stay, an expected average of 1 week

  6. Proportion of 30 day - readmission

    Readmission until 30 days after the Emergency Department admission (Central Denmark Region)

    Measured: Participants will be followed for the duration of 30 days after the hospital stay

  7. Length of stay in the Emergency Departments

    The length of time patients spend in the Emergency Department

    Measured: Participants will be followed for the duration of the hospital stay in the Emergency Department, an expected average of 17 hours

  8. Length of stay in the Hospital

    The length of time patients spend in the hospital

    Measured: Participants will be followed for the duration of hospital stay, an expected average of 1 week

  9. Proportion of in-hospital death

    The proportion of participants who die in the hospital

    Measured: Participants will be followed for the duration of hospital stay, an expected average of 1 week

  10. Proportion of in-hospital cardiac/respiratory arrest

    The proportion of participants who have a cardiac or respiratory arrest in the hospital

    Measured: Participants will be followed for the duration of hospital stay, an expected average of 1 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Mar 2018
  2. Study start30 Oct 2017
  3. Primary completion31 May 2018
  4. Study completion31 May 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
The study consists of two intervention and two control departments. The intervention consists of a risk assesment to ensure systematic and standardized identification of patients in risk of clinical deterioration and a decision support algorithm. Actions are undertaken on the basis of the standardized decision support and when a patient is determined to be at risk escalation plans are activated. As part of the intervention, huddles are conducted and patients at risk are interdisciplinarily discussed.
Masking
None (open label)
Enrolment
34,556 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03457272
Sponsor's protocol ID
18296453
Status last verified
Oct 2019
First submitted
4 Dec 2017
Last updated
14 Oct 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing New risk assessment in people with Emergency Medicine, run by University of Aarhus at 4 sites in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Oct 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The proportion of patients with severe clinical deterioration in the ED (time frame: Participants will be followed for the length of stay in the Emergency Department, an expected period of 48 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Oct 2019; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in